Document is current

Article History

Accepted: 30 April 2021

First Online: 29 June 2021

Declarations

:

: Mohammed Dawod declares that he has no conflict of interest.Teresa Alonso Gordoa has received compensation for service as a consultant/advisory board member from Ipsen, Advanced Accelerator Applications (AAA), Roche, Pfizer, Sanofi, Bayer, Janssen, Astellas, Bristol-Myers Squibb, Merck, and Eisai; and has received speaker's honoraria from Ipsen, AAA, Pfizer, Janssen, and Astellas.Mauro Cives has received travel Support from Ipsen, Novartis, Pfizer, and AAA; has received speaker's honoraria from Ipsen, Novartis, and AAA; and has received compensation for service on advisory boards from AAA.Louis De Mestier has received compensation for service on advisory boards from Ipsen, Novartis, and Pfizer; and has received speaker's honoraria from Ipsen, Novartis, Pfizer, and Keocyt.Joakim Crona has received educational honoraria from Novartis.Francesca Spada has received funding for clinical trials from GETNE, Incyte Corporation, and MSD; has received speaker's and advisory honoraria from Ipsen, Novartis, Pfizer, AAA, and Merck; is the coordinator of neuroendocrine neoplasms guidelines for Associazone Italiana di Oncologia Medica (AIOM), and an executive board member for the Italian Association for Neuroendocrine Tumours (ITANET).Kjel Oberg has received compensation for service as a consultant from Ipsen.Marianne Pavel has received honoraria for presentations and/or advisory roles from Novartis, Ipsen, AAA, Pfizer, Riemser, Lexicon Pharmaceuticals, prIME Oncology, and Boehringer Ingelheim.Angela Lamarca has received travel and educational support from Ipsen, Pfizer, Bayer, AAA, Sirtex Medical, Novartis, Mylan, and Delcath Systems; has received speaker's honoraria from Merck, Pfizer, Ipsen, Incyte Corporation, and AAA; and has received advisory honoraria from Eisai, Nutricia, Ipsen, QED Therapeutics, and Roche.